Symtuza 800/150/200/10 mg tablets: overview
Quick summary: Symtuza is a fixed-dose combination tablet used for the treatment of HIV-1 in adults and some adolescents. It contains darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in one film-coated tablet. This overview explains...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Symtuza is a fixed-dose combination tablet used for the treatment of HIV-1 in adults and some adolescents. It contains darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in one film-coated tablet.
This overview explains what the medicine contains, how it is usually taken, and the main precautions to review with a healthcare professional or official patient leaflet.
Medical disclaimer: This article is for general information only. It does not replace advice from a doctor, pharmacist, or the official product information. Do not use it to diagnose a condition or to change any prescribed treatment.
What is Symtuza?
Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets is a fixed-dose combination medicine used for the treatment of HIV-1. It brings four active ingredients together in one tablet, which can make daily treatment simpler for some patients.
The tablet is intended for adults and adolescents who meet the product’s age and weight criteria described in the official information.
What ingredients does Symtuza contain?
Each film-coated tablet contains the following active ingredients:
- Darunavir 800 mg
- Cobicistat 150 mg
- Emtricitabine 200 mg
- Tenofovir alafenamide 10 mg
These ingredients work together as part of antiretroviral treatment for HIV-1.
How is Symtuza usually taken?
Symtuza is generally taken as one tablet once daily with food. Taking it with food is important because the official instructions say it should be taken this way.
If a dose is missed, the usual advice is to follow the instructions in the patient leaflet or from a healthcare professional. Do not take extra tablets to make up for a missed dose unless specifically told to do so.
Who should review Symtuza carefully before use?
Before starting treatment, it is important to review the medicine with a doctor or pharmacist, especially if the person has:
- Any known allergy or sensitivity to one of the ingredients
- Liver problems, including severe liver impairment
- Kidney concerns
- A history of HIV treatment, including previous antiretroviral therapy
- Other medicines, supplements, or herbal products being taken at the same time
In some situations, additional testing may be used to help guide treatment decisions.
What precautions are mentioned for Symtuza?
The original content highlights several precautions that may be considered during treatment:
- Monitoring of liver and kidney function
- Careful review in older adults or people with renal problems
- Assessment of treatment history in people who have used antiretroviral therapy before
These points are part of routine medication review and follow-up, especially for long-term HIV treatment.
What drug interactions should be checked?
Symtuza may interact with other medicines. Because of this, it is important to tell a healthcare professional about all prescription medicines, over-the-counter products, supplements, and herbal remedies being used.
The original content notes that medicines affecting liver metabolism, some other antiretrovirals, and certain supplements or herbs may be relevant. A pharmacist can help check for possible interactions using the full medicine list.
What should patients know before starting treatment?
Before treatment begins, patients are usually advised to understand the following:
- HIV treatment works best when taken consistently as prescribed
- Any unusual symptoms should be reported to a healthcare professional
- Regular follow-up appointments and lab checks may be needed
- Symtuza helps manage HIV-1, but it does not cure HIV
Key points at a glance
| Topic | Summary |
|---|---|
| Medicine type | Fixed-dose combination antiretroviral tablet |
| Use | Treatment of HIV-1 |
| How it is taken | Usually one tablet once daily with food |
| Main review points | Allergies, liver and kidney health, other medicines, and treatment history |
Frequently asked questions
▸ Does Symtuza need to be taken with food?
Yes. The original content states that Symtuza should be taken with food.
▸ What is Symtuza prescribed for?
It is prescribed for the treatment of HIV-1 in adults and eligible adolescents.
▸ What are the active ingredients in Symtuza?
Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide.
▸ Can Symtuza interact with other medicines?
Yes. The medicine may interact with other treatments, so a full medicine review is important before use.
▸ Does Symtuza cure HIV?
No. The original content states that it helps control HIV-1, but it does not cure HIV.
Safety reminder: Always check the official leaflet and speak with a doctor or pharmacist if you have questions about use, interactions, monitoring, or missed doses. Seek urgent medical help for severe or unexpected symptoms.
Sources to verify
For the most accurate and up-to-date information, readers should verify details in the official product leaflet and trusted medicines references.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.